| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of GLO1 mRNA | CTD | PMID:17108234 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:10653 | 6480464 | Ethinyl Estradiol results in increased expression of GLO1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10653 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GLO1 mRNA | CTD | PMID:18343893 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1350387 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GLO1 mRNA | CTD | PMID:22574217 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10653 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GLO1 mRNA | CTD | PMID:18796159 PMID:16922920 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10653 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GLO1 mRNA | CTD | PMID:15328365 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:10653 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GLO1 mRNA | CTD | PMID:16922920 PMID:18796159 |
| 3,4-dihydroxybenzoic acid | multiple interactions | ISO | RGD:10653 | 6480464 | protocatechuic acid inhibits the reaction [Galactose results in decreased expression of and results in decreased activity of GLO1 protein] | CTD | PMID:22687555 |
| 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:10653 | 6480464 | 1,2-dithiol-3-thione results in decreased expression of GLO1 mRNA | CTD | PMID:15302862 |
| aflatoxin B1 | increases expression | ISO | RGD:10653 | 6480464 | Aflatoxin B1 results in increased expression of GLO1 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10653 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of GLO1 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1350387 | 6480464 | Methionine inhibits the reaction [Benzo(a)pyrene results in decreased expression of GLO1 protein] | CTD | PMID:22138271 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1350387 | 6480464 | Benzo(a)pyrene results in decreased expression of GLO1 protein | CTD | PMID:22138271 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of GLO1 mRNA | CTD | PMID:21839799 |
| cadmium dichloride | decreases methylation | EXP | | 6480464 | Cadmium Chloride results in decreased methylation of GLO1 promoter | CTD | PMID:22457795 |
| copper atom | increases expression | ISO | RGD:10653 | 6480464 | Copper results in increased expression of GLO1 mRNA | CTD | PMID:17205981 |
| copper(0) | increases expression | ISO | RGD:10653 | 6480464 | Copper results in increased expression of GLO1 mRNA | CTD | PMID:17205981 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1350387 | 6480464 | Copper Sulfate results in decreased expression of GLO1 mRNA | CTD | PMID:19549813 |
| cyclosporin A | decreases expression | ISO | RGD:10653 | 6480464 | Cyclosporine results in decreased expression of GLO1 mRNA | CTD | PMID:19770486 |
| desferrioxamine B | multiple interactions | ISO | RGD:1350387 | 6480464 | ferric ammonium citrate inhibits the reaction [Deferoxamine results in increased expression of GLO1 protein] | CTD | PMID:19515424 |
| desferrioxamine B | increases expression | ISO | RGD:1350387 | 6480464 | Deferoxamine results in increased expression of GLO1 protein | CTD | PMID:19515424 |
| diarsenic trioxide | increases expression | ISO | RGD:1350387 | 6480464 | arsenic trioxide results in increased expression of GLO1 mRNA | CTD | PMID:20458559 |
| doxorubicin | multiple interactions | ISO | RGD:1350387 | 6480464 | troglitazone inhibits the reaction [GLO1 mRNA results in decreased susceptibility to Doxorubicin]; more ... | CTD | PMID:16085563 |
| doxorubicin | decreases response to substance | ISO | RGD:1350387 | 6480464 | GLO1 mRNA results in decreased susceptibility to Doxorubicin | CTD | PMID:16085563 |
| doxorubicin | multiple interactions | ISO | RGD:10653 | 6480464 | GLO1 protein results in decreased susceptibility to [Indomethacin co-treated with Doxorubicin]; more ... | CTD | PMID:17243824 |
| ferric ammonium citrate | multiple interactions | ISO | RGD:1350387 | 6480464 | ferric ammonium citrate inhibits the reaction [Deferoxamine results in increased expression of GLO1 protein] | CTD | PMID:19515424 |
| fluoxetine | increases response to substance | ISO | RGD:10653 | 6480464 | GLO1 protein results in increased susceptibility to Fluoxetine | CTD | PMID:22113448 |
| galactose | multiple interactions | ISO | RGD:10653 | 6480464 | Galactose results in decreased expression of and results in decreased activity of GLO1 protein; more ... | CTD | PMID:22687555 |
| gliclazide | multiple interactions | EXP | | 6480464 | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of GLO1 protein] | CTD | PMID:21439372 |
| glycolaldehyde | decreases activity | EXP | | 6480464 | glycolaldehyde results in decreased activity of GLO1 protein | CTD | PMID:21378371 |
| indomethacin | multiple interactions | ISO | RGD:10653 | 6480464 | GLO1 protein results in decreased susceptibility to [Indomethacin co-treated with Doxorubicin]; more ... | CTD | PMID:17243824 |
| L-ascorbic acid | affects expression | ISO | RGD:10653 | 6480464 | Ascorbic Acid affects the expression of GLO1 protein | CTD | PMID:19224539 |
| L-methionine | multiple interactions | ISO | RGD:1350387 | 6480464 | Methionine inhibits the reaction [Benzo(a)pyrene results in decreased expression of GLO1 protein] | CTD | PMID:22138271 |
| methamphetamine | increases expression | EXP | | 6480464 | Methamphetamine results in increased expression of GLO1 protein | CTD | PMID:19826936 |
| methylglyoxal | affects response to substance | ISO | RGD:1350387 | 6480464 | GLO1 protein affects the susceptibility to Pyruvaldehyde | CTD | PMID:20093988 |
| methylglyoxal | multiple interactions | ISO | RGD:1350387 | 6480464 | GLO1 protein affects the reaction [Pyruvaldehyde binds to HSPB1 protein] | CTD | PMID:20093988 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:10653 | 6480464 | Diethylnitrosamine results in increased expression of GLO1 mRNA | CTD | PMID:17942915 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:10653 | 6480464 | MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of GLO1 mRNA] | CTD | PMID:17942915 |
| nicotinamide | multiple interactions | EXP | | 6480464 | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of GLO1 protein]; more ... | CTD | PMID:21439372 |
| okadaic acid | decreases expression | ISO | RGD:1350387 | 6480464 | Okadaic Acid results in decreased expression of GLO1 protein | CTD | PMID:19397276 |
| okadaic acid | multiple interactions | ISO | RGD:1350387 | 6480464 | [Okadaic Acid co-treated with gambierol] results in decreased expression of GLO1 protein | CTD | PMID:19397276 |
| paracetamol | affects expression | ISO | RGD:10653 | 6480464 | Acetaminophen affects the expression of GLO1 mRNA | CTD | PMID:17562736 |
| pirinixic acid | decreases expression | ISO | RGD:10653 | 6480464 | pirinixic acid results in decreased expression of GLO1 mRNA | CTD | PMID:18445702 |
| pirinixic acid | increases expression | ISO | RGD:10653 | 6480464 | pirinixic acid results in increased expression of GLO1 mRNA | CTD | PMID:18301758 |
| quercetin | increases expression | ISO | RGD:1350387 | 6480464 | Quercetin results in increased expression of GLO1 protein | CTD | PMID:17292933 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of GLO1 protein] | CTD | PMID:21439372 |
| resveratrol | increases activity | EXP | | 6480464 | resveratrol results in increased activity of GLO1 protein | CTD | PMID:21439372 |
| silicon dioxide | decreases activity | ISO | RGD:1350387 | 6480464 | Silicon Dioxide results in decreased activity of GLO1 protein | CTD | PMID:19679115 |
| silicon dioxide | decreases expression | ISO | RGD:1350387 | 6480464 | Silicon Dioxide results in decreased expression of GLO1 mRNA | CTD | PMID:19679115 |
| streptozocin | multiple interactions | EXP | | 6480464 | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of GLO1 protein]; more ... | CTD | PMID:21439372 |
| sulindac | decreases activity | ISO | RGD:10653 | 6480464 | Sulindac results in decreased activity of GLO1 protein | CTD | PMID:17243824 |
| tolmetin | decreases activity | ISO | RGD:10653 | 6480464 | Tolmetin results in decreased activity of GLO1 protein | CTD | PMID:17243824 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased activity of GLO1 protein] | CTD | PMID:21439372 |
| trans-resveratrol | increases activity | EXP | | 6480464 | resveratrol results in increased activity of GLO1 protein | CTD | PMID:21439372 |
| trichloroethene | decreases expression | ISO | RGD:10653 | 6480464 | Trichloroethylene results in decreased expression of GLO1 mRNA | CTD | PMID:19448997 |
| troglitazone | multiple interactions | ISO | RGD:1350387 | 6480464 | troglitazone inhibits the reaction [GLO1 mRNA results in decreased susceptibility to Doxorubicin]; more ... | CTD | PMID:16085563 |
| troglitazone | decreases activity | ISO | RGD:1350387 | 6480464 | troglitazone results in decreased activity of GLO1 protein | CTD | PMID:12572858 PMID:11719831 |
| troglitazone | decreases activity | EXP | | 6480464 | troglitazone results in decreased activity of GLO1 mRNA; more ... | CTD | PMID:11719831 |
| troglitazone | decreases activity | ISO | RGD:1350387 | 6480464 | troglitazone results in decreased activity of GLO1 protein | CTD | PMID:11719831 PMID:12572858 |
| troglitazone | decreases activity | ISO | RGD:1350387 | 6480464 | troglitazone results in decreased activity of GLO1 mRNA | CTD | PMID:11719831 |
| troglitazone | decreases expression | ISO | RGD:1350387 | 6480464 | troglitazone results in decreased expression of GLO1 mRNA | CTD | PMID:12572858 |
| troglitazone | decreases activity | ISO | RGD:1350387 | 6480464 | troglitazone results in decreased activity of GLO1 protein | CTD | PMID:12572858 |
| uranium atom | affects expression | ISO | RGD:1350387 | 6480464 | Uranium affects the expression of GLO1 mRNA | CTD | PMID:15672453 |
| zomepirac | decreases activity | ISO | RGD:10653 | 6480464 | zomepirac results in decreased activity of GLO1 protein | CTD | PMID:17243824 |